Effect of spironolactone on the progression of coronary calcification in peritoneal dialysis patients: a pilot study.
CONCLUSION: In peritoneal dialysis patients, spironolactone did not attenuate the progression of CC. However, large-scale studies are needed to confirm this observation. Disorders of mineral metabolism and dyslipidemia are involved in the progression of CC.
PMID: 31419271 [PubMed - as supplied by publisher]
Source: Jornal Brasileiro de Nefrologia - Category: Urology & Nephrology Tags: J Bras Nefrol Source Type: research
More News: Calcium | Cholesterol | CT Scan | Dialysis | Peritoneal Dialysis | Spironolactone | Study | Urology & Nephrology